Using the ResCu system for preclinical testing of KRAS G12C inhibitors

被引:0
|
作者
Ruiz, Victor M. [1 ]
Hill, Lindsay [1 ]
Gadde, Manasa [1 ]
Bulow, Christopher [1 ]
Morri, Maurizio [1 ]
Goldner, Nicholas [1 ]
机构
[1] ResistanceBio, San Carlos, CA USA
关键词
D O I
10.1158/1557-3125.RAS23-B030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B030
引用
收藏
页数:1
相关论文
共 50 条
  • [31] KRAS G12C inhibitors in metastatic colorectal cancer: a tale of two targets
    Martinez-Perez, Julia
    Valladares-Ayerbes, Manuel
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [32] Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors
    Timar, Jozsef
    Baranyi, Marcell
    Molnar, Eszter
    Randelovic, Ivan
    Cserepes, Mihaly
    Tovari, Jozsef
    Hegedus, Balazs
    CANCER RESEARCH, 2024, 84 (07)
  • [33] KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
    Lim, Tony Kiat Hon
    Skoulidis, Ferdinandos
    Kerr, Keith M.
    Ahn, Myung-Ju
    Kapp, Joshua R.
    Soares, Fernando A.
    Yatabe, Yasushi
    LUNG CANCER, 2023, 184
  • [34] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [35] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Li, Lian-Sheng
    Hansen, Rasmus
    Rosen, Neal
    SCIENCE, 2016, 351 (6273) : 604 - 608
  • [36] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [37] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [38] KRAS (G12C) mediated mRNA translation program
    Singh, Kamini
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [39] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [40] Toxicities Associated with Immune Checkpoint Inhibitors Followed by KRAS G12C Inhibitors in Patients with Metastatic NSCLC
    Kagalwalla, S.
    Patel, M.
    Fujioka, N.
    Manning, B.
    Kratzke, R.
    Kulkarni, A. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S648 - S649